Evidence map›Paper›PMID 42564525›Full record

ArticleAfrican health sciences2026

Non-Adherence and First Line Antiretroviral Therapy failure among people living with HIV on Antiretroviral Therapy in Bulawayo city, 2016.

Martin Tatenda Dzimbanhete, Gerald Shambira, Mufuta Tshimanga, Notion Tafara Gombe, Zanele Hwalima, Chiedza Sibanda, Cleophas Chimbetete

Abstract read
In one paragraph

Article in African health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Martin Tatenda DzimbanheteDepartment of Community Medicine, University of Zimbabwe.
Gerald ShambiraDepartment of Community Medicine, University of Zimbabwe.
Mufuta TshimangaDepartment of Community Medicine, University of Zimbabwe.
Notion Tafara GombeDepartment of Community Medicine, University of Zimbabwe.
Zanele HwalimaBulawayo City Health Services Department.
Chiedza SibandaBulawayo City Health Services Department.
Cleophas ChimbeteteNewlands Clinic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of first-line ART failure in Bulawayo City, Zimbabwe's second-largest city for the year 2016 was 6.6% higher than the national average of 3.3%. We assessed the association between non-adherence and first-line ART failure persons on ART in Bulawayo City. Methods: A 1:1 case-control study was done to measure the association between adherence and other risk factors for treatment failure among 169 cases and 169 controls. The Morisky Medication adherence 8-item scale was used to assess self-reported adherence, and non-adherence was defined as having a self-reported score of 1 to 8. Epi info 7 was used for univariate, bivariate, and multivariate analysis. Results: Persons who were non-adherent to ART were 5 times more likely to experience treatment failure than those who adhered association between non-adherence and treatment failure (OR=5.1, 95% CI 2.9-8.9). The study established that 58% of the cases had good knowledge of adherence to ART compared to 85% of the controls. Stopping medication when feeling worse (AOR=3.5, 95% CI 1.8-7.0) was the most significant independent risk factor for treatment failure. Conclusions: The study found a strong association between non-adherence and treatment failure. Routine monitoring at every clinic visit of clients on ART should be done to monitor the client's adherence to medication.

Indexed as

Anti-HIV AgentsDrug MonitoringHIV InfectionsMedication AdherenceAdultCase-Control StudiesFemaleHumansMaleMiddle AgedRisk FactorsTreatment FailureYoung AdultZimbabweAnti-HIV AgentsBulawayo CityFirst line Antiretroviral Therapy FailureNon-adherence

Identifiers

PMID42564525
PMCPMC13444309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.